Back to Journals » Cancer Management and Research » Volume 12
Original Research
High Systemic Immune-Inflammation Index Predicts Poor Survival in Patients with Human Epidermal Growth Factor Receptor-2 Positive Breast Cancer Receiving Adjuvant Trastuzumab
Total article views | HTML views | PDF downloads | Totals | ||
---|---|---|---|---|---|
6,837 | Dovepress* | 6,396+ | 1,002 | 7,398 | |
PubMed Central* | 441 | 206 | 647 | ||
Totals | 6,837 | 1,208 | 8,045 | ||
*Since 21 January 2020 |
View citations on PubMed Central and Google Scholar